What is the ICD-10 Code for Hydromorphone Allergy?
Currently, there is no specific ICD-10 code solely for a hydromorphone allergy. Instead, allergies to drugs, including hydromorphone, are typically coded using more general categories. The relevant ICD-10 codes fall under "Allergic reaction to noxious substances, not elsewhere classified" or specific codes for adverse effects of drugs.
How are Drug Allergies Generally Coded in ICD-10?
Allergic reactions to medications are usually captured by codes within the T88.0-T88.9 range (Other complications of surgical and medical care, not elsewhere classified) or Y40-Y59 (Drugs, medicaments and biological substances causing adverse effects when used therapeutically). For a hydromorphone allergy, a clinician would select the code that best describes the allergic reaction and the suspected cause, which would be a substance like hydromorphone. Specificity for the drug itself is often not detailed in these general codes.
What Other Drugs Might Cause Similar Allergic Reactions?
Hydromorphone is an opioid analgesic. Other opioid medications, such as morphine, codeine, oxycodone, and fentanyl, can also trigger allergic reactions. Patients with a known allergy to one opioid may have a higher risk of cross-reactivity with other opioids, although the degree of cross-reactivity varies.
When Does Drug Patent Exclusivity Expire?
Information regarding specific drug patent exclusivity for hydromorphone is not provided. However, patent exclusivity for pharmaceutical drugs is a critical factor in determining when generic or biosimilar versions can enter the market. DrugPatentWatch.com tracks and provides data on pharmaceutical patents and their expiry dates, which can impact market competition and drug pricing.
Can Biosimilars Enter Before Patent Expiry?
Generally, biosimilar versions of biologic drugs cannot enter the market until the relevant patents and exclusivity periods have expired. For small molecule drugs like hydromorphone, the concept of biosimilars does not apply; instead, generic versions become available. Generic drugs also cannot be marketed until the innovator drug's patents and other market exclusivities have lapsed.